{
    "clinical_study": {
        "@rank": "109358", 
        "acronym": "nexgen", 
        "arm_group": [
            {
                "arm_group_label": "Comprehensive Chromosome Screening", 
                "arm_group_type": "Experimental", 
                "description": "Trophectoderm biopsy will be performed on all blastocysts and CCS via next generation sequencing screening performed on biopsy samples. Patients will proceed with a Double Embryo Transfer (DET) of the two morphologically best euploid embryos"
            }, 
            {
                "arm_group_label": "No Comprehensive Chromosome Screening", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The patients in this group will proceed with a Double Embryo Transfer (DET) of the two morphologically best embryos."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the benefits of using next generation sequencing to assess embryonic aneuploidy.\n       All viable blastocysts will be biopsied and cryopreserved for  future transfer.   After the\n      final embryo is cryopreserved, patients will be randomized to either the intervention group\n      or the control group. Patients and doctors are blinded to the randomization until study\n      completion. A Double Embryo Transfer (DET) will be performed with either screened or\n      unscreened embryos depending on randomization. A Single Embryo Transfer (SET) may occur in\n      cases where only one embryo is available for transfer."
        }, 
        "brief_title": "Next Generation Sequencing Screening for Embryonic Ploidy Status", 
        "completion_date": {
            "#text": "October 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient undergoing IVF/CCS (no PGD banking)\n\n          -  Patient meets ASRM guidelines for Double Embryo Transfer (DET)\n\n          -  Donor Sperm OK\n\n          -  AMH \u2265 1.2\n\n          -  FSH \u2264 12\n\n          -  BAFC \u226512\n\n          -  Max 1 prior failed IVF cycle for patients 35-45 years old\n\n          -  Patient <35 years old MUST have 1 prior failed IVF cycle\n\n        Exclusion Criteria:\n\n          -  Chronic endometrial insufficiency\n\n          -  Use of oocyte donor or gestational carriers\n\n          -  Medical contraindications to Double Embryo Transfer (DET)\n\n          -  Male Factor (<100,000 sperm or surgical sperm)\n\n          -  Communicating hydrosalpinx (on HSG)\n\n          -  Single gene disorders or sex selection"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "42 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "250", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02032264", 
            "org_study_id": "RMA-2013-04"
        }, 
        "intervention": {
            "arm_group_label": "Comprehensive Chromosome Screening", 
            "description": "On day 6 of embryo development, all embryos will undergo a trophectoderm biopsy using the standardized technique, as according to standard laboratory protocol and without regard to study. Comprehensive Chromosome Screening (CCS), will be performed via next generation sequencing and results will be available at the time of study completion.", 
            "intervention_name": "Comprehensive Chromosome Screening", 
            "intervention_type": "Other", 
            "other_name": [
                "PGD", 
                "CCS"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Next generation sequencing", 
            "Embryonic aneuploidy"
        ], 
        "lastchanged_date": "January 9, 2014", 
        "link": {
            "description": "Reproductive Medicine Associates of New Jersey", 
            "url": "http://www.rmanj.com/"
        }, 
        "location": {
            "contact": {
                "email": "clinicalresearchteam@rmanj.com", 
                "last_name": "Christine V Reda, BSN, RN", 
                "phone": "973-656-2841"
            }, 
            "contact_backup": {
                "email": "clinicalresearchteam@rmanj.com", 
                "last_name": "Janine M Casciello, BA", 
                "phone": "973-656-2841"
            }, 
            "facility": {
                "address": {
                    "city": "Basking Ridge", 
                    "country": "United States", 
                    "state": "New Jersey", 
                    "zip": "07920"
                }, 
                "name": "Reproductive Medicine Associates of New Jersey"
            }, 
            "investigator": {
                "last_name": "Richard T Scott, M.D., HCLD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of the Efficacy of Next Generation Sequencing in Predicting Embryonic Karyotype and Subsequent Pregnancy Outcomes in in Vitro Fertilization Cycles (IVF)", 
        "overall_contact": {
            "email": "clinicalresearchteam@rmanj.com", 
            "last_name": "Christine V Reda, BSN, RN", 
            "phone": "973-656-2841"
        }, 
        "overall_contact_backup": {
            "email": "clinicalresearchteam@rmanj.com", 
            "last_name": "Janine M Casciello, BA", 
            "phone": "973-656-2841"
        }, 
        "overall_official": {
            "affiliation": "Reproductive Medicine Associates of New Jersey", 
            "last_name": "Richard T Scott, M.D., HCLD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate the benefits, if any, of using next generation sequencing based Comprehensive Chromosome Screening (CCS) in the selection of embryos for transfer during clinical IVF cycles", 
            "measure": "Impact of next generation sequencing on the embryos produced from IVF on implantation rates", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02032264"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Delivery Rates", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "Reproductive Medicine Associates of New Jersey", 
        "sponsors": {
            "collaborator": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Reproductive Medicine Associates of New Jersey", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}